Trial Profile
Evaluation of the Suitability of a 5-ALA Patch (PD P 506 A, Alacare®) in the Photodynamic Therapy (PDT) of Actinic Keratosis on the Upper Extremities
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors Photonamic
- 27 Aug 2019 Status changed from recruiting to completed.
- 04 Dec 2018 Planned End Date changed from 1 Jan 2019 to 1 Mar 2019.
- 04 Dec 2018 Planned primary completion date changed from 1 Jan 2019 to 1 Mar 2019.